Introduction: Transmembrane sodium-independent glucose transporters (GLUTs) play an important role in both placental and fetal development by the providing transplacental glucose transport. Abnormal GLUT-1 and GLUT-3 placental expression could play a role in such late pregnancy complications development as preeclampsia and intrauterine growth retardation. Materials and Methods: Immunohistochemistry was performed to reveal patterns of GLUT-1 and GLUT-3 expression in the placental terminal villi compartments. Results: GLUT-1 syncytial expression in the terminal villi of severe PE cases (both with and without IUGR) was significantly lower in compare to control group. We also report about GLUT-3 both syncytial and endothelial expression in the near term and term placental terminal villi without significant difference between the study and control groups. Conclusion: other study should be performed to establish the nature of GLUT-1 downregulation in severe preeclampsia cases and whether GLUT-3 is expressed in the syncytiotrophoblast of near term and term placentas or not.
INTRODUCTION
Preeclampsia being one of the most severe pregnancy complications accounts about 12% of all maternal mortality cases [1] . Basic pathogenic events in PE development are abnormal trophoblastic invasion and spiral arteries remodeling later leading to utero-placental hypoxia [2] . Some cases of PE are also complicated by intrauterine growth retardation [3] .
Oxygen is the key substrate for normal fetal development and growth therefore hypoxia is a leading cause of fetal growth restriction. After oxygen, glucose is the most important substrate for fetal growth and the only one that can be metabolized anaerobically [4] . The second important cause of IUGR reduces glucose transfer to the fetus. Placenta is a source of alterations that lead to the reduced maternal-fetal glucose transfer. At least partially this could be due to the decreased placental glucose transporters (GLUT) expression, since previous data have suggested that transport across the basal membrane is the rate-limiting step in transplacental glucose transport [5] . GLUTs are the members of sodium-independent transmembrane proteins that provide intracellular glucose transport [6] . These molecules could play an important role in the development of fetal growth restriction in preeclampsia but its importance is not established yet. The aim of this study is to analyze glucose transporters GLUT-1 and GLUT-3 expression patterns in the terminal villi of the placentas from PE and IUGR cases.
MATERIALS AND METHODS
A cross section morphological and immunohistochemical study of 31 placentas from preeclampsia-complicated pregnancies with and without IUGR and 13 placentas from uncomplicated pregnancies was performed. Inclusion criteria were singleton pregnancy, moderate and severe PE, severe PE combined with IUGR. Other pregnancy complications, extragenital pathology and fetal abnormalities were exclusion criteria. Clinical characteristic of the study groups is presented in Table 1 .
Gross examination of all the placentas was performed. Placental weight was measured after trimming the cord and membranes. Tissue samples were obtained from the central parts of placental disk for microscopy and immunohistochemistry and fixed with 10% buffered formalin. H & E stained slides were then prepared and studied microscopically.
Immunohistochemical study was performed on 3 -4 mcm slides with GLUT-1 monoclonal mouse (1:100, Abcam, Great Britain) and polyclonal rabbit GLUT-3 (1:50, Abcam, Great Britain) antibodies.
Data are presented as mean ± SD. Statistical analysis was performed using the Statistica 8 (StatSoft Inc, USA) software. Data were measured by analysis of variance using the Scheffe post hoc test. A value of p < 0.05 was taken as significant.
RESULTS

Pregnancy Characteristics
No significant difference in maternal age and body mass index was observed between the study and control groups. Gestational age in both severe PE and severe PE with IUGR was significantly lower in compare to control and moderate PE groups (p < 0.05).
Newborn body weight in both severe PE and severe PE with IUGR groups was significantly lower, than in control group (p < 0.05). No difference in placental weight was observed between moderate and severe PE in compare to control (p > 0.05) with only significantly lower placental weight in severe PE with IUGR group in compare to control (p < 0.05). No significant difference in placental/newborn weight index was also observed (p > 0.05).
Placental Histology
In 3 cases of moderate, 4 of severe PE and 5 of severe PE with IUGR cases sign of villous maldevelopment that 
Immunohistochemistry
GLUT-1 syncytial expression (Figure 1) in the terminal villi of severe PE cases placentas (both with and without IUGR) was significantly lower in compare to control group (Figure 2) (p = 0.004, p = 0.003, accordingly) (Figure 3) . GLUT-1 terminal villi endothelial expression in moderate PE and severe PE with IUGR groups was insignificantly lower in compare to control (p > 0.05). The only significant difference in GLUT-1 endothelial expression was observed in severe PE group without IUGR (p = 0.01). Both syncytial and endothelial GLUT-3 expression (Figures 4 and 5) level was insignificantly lower in all the study groups in compare to control (p > 0.05). GLUT-1 syncytial-endothelial gradient was lower in all the study groups in compare to control, but the difference was only significantly in severe PE with IUGR group (1.27 versus 1.47, p = 0.03). GLUT-3 syncytial-endothelial gradient was also lower in all the study groups but without significance (p > 0.05).
DISCUSSION
Glucose is essential for the development of the fetus. After oxygen, which is absolutely necessary for fetal development, glucose is the second important substrate for fetal growth and the only one that can be metabolized anaerobically. The growing glucose requirements of the fetus throughout pregnancy must be met by increases in placental transport capacity, which is mediated by the specific transmembrane glucose transporters (GLUTs). GLUTs are the members of sodium-independent transmembrane proteins that provide intracellular glucose transport [6] . A group of these molecules consists of at least 12 isoforms. While many of these isoforms have been identified in human placental tissue, it is important to note that the only transporter present in the syncytium as a functional protein near term is the GLUT-1 isoform.
In an experiment on rabbits [7] immunohistochemistry indicated the distribution of GLUT-1 was observed mainly to the surface of the outer trophoblasts, whereas GLUT-3 mainly localized to the basal site of the inner trophoblasts and fetal blood vessels, suggesting that glucose is transported through GLUT-1 from the maternal blood stream for use as a placental fuel and for further transport through GLUT-3 to the fetal circulation. According to the data maximal GLUT-1 syncytial expression is seen near term [8, 9] . It is also important to note that GLUT-1 concentration in the syncytial microvilli is 3 times higher than in syncytial basal membrane. This asymmetry reflects GLUT-1 transport activity, because basal membrane is thought to be a key limiting step in transplacental glucose transport [6] . We revealed GLUT-1 syncytial expression in control and all the study groups and it is important to note that GLUT-1 syncytial expression in the terminal villi of severe PE cases (both with and without IUGR) was significantly lower in compare to control group. Study suggests, that clear hypoxia increases glucose transporter expression in the trophoblast cells is to [10, 11] . We revealed no difference between GLUT-1 terminal villi endothelial expression in moderate PE and severe PE with IUGR and control group. The only significant difference in GLUT-1 endothelial expression was observed in severe PE group without IUGR. Therefor the nature of GLUT-1 decreased syncytial and endothelial expression in severe PE cases is still unclear in additional studies should be performed to reveal it.
Conflicting information regarding expression of GLUT-3 protein in the human placenta has been reported and the localization and pattern of expression of GLUT-3 protein across gestation has not been clearly defined. Some data suggest that GLUT-3 expression in term and near term pregnancy placenta is absent in syncytiotrophoblast, other-that that it is localized mainly in the syncytial basal membrane [7, 12, 13] . Recent study reports that immunohistochemistry localizes GLUT-3 expression to the syncytiotrophoblast although there is also expression in the cytotrophoblast and to some degree in the endothelium. Western blotting shows that GLUT-3 is expressed in the microvillous but not basal membranes of the syncytium [14] . Other experimental study shows that in the placentas of rats under chronic maternal restraint stress placental GLUT-1 protein levels decreases whereas GLUT-3 protein levels slightly increases [15] . In the study we report about GLUT-3 both syncytial and endothelial expression in the near term and term placental terminal villi. Both syncytial and endothelial GLUT-3 expression level was insignificantly lower in all the study groups in compare to control.
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CONCLUSION
Downregulated GLUT-1 expression in syncytiotrophoblast of the terminal villi could play a role in IUGR development in cases of severe preeclampsia. But the nature of GLUT-1 decreased syncytial and endothelial expression in severe PE cases is still unclear in additional studies should be performed to reveal it. Other study should be performed to establish whether GLUT-3 is expressed in syncytium of the preterm and term placental terminal villi or not. Also the role of GLUTs in preeclampsia development needs to be established.
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